RENOSIS

Live / Applied — Second extension granted (statement of use) (as of 21 Oct 2025)

What this means for you

Not registered yet, but its 05 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98165682
Mark type
Stylized text
Filed
05 Sept 2023
Published for opposition
03 Sept 2024
Attorney of record
Brandon P. Leahy

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of heart conditions, diseases, and disorders, kidney conditions, diseases, and disorders, liver conditions, disease, and disorders, acute kidney injury (AKI), and cardio-renal conditions, diseases, and disorders; pharmaceutical preparations for treatment of patients following cardiothoracic surgery; anti-inflammatories; pharmaceutical preparations for preventing progression of metabolic diseases and conditions, namely, chronic kidney disease, cardiovascular, pulmonary, and metabolic conditions; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for reducing metabolic acidosis

Owner

Prosecution history

  • 22 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 21 Oct 2025 — SOU EXTENSION 2 GRANTED
  • 21 Oct 2025 — SOU EXTENSION 2 FILED
  • 21 Oct 2025 — SOU TEAS EXTENSION RECEIVED
  • 24 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 24 Apr 2025 — SOU EXTENSION 1 GRANTED
  • 23 Apr 2025 — SOU EXTENSION 1 FILED
  • 23 Apr 2025 — SOU TEAS EXTENSION RECEIVED
  • 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 03 Sept 2024 — PUBLISHED FOR OPPOSITION
  • 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 28 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 23 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 23 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy